Vice President Finance for Emerging Market Central unit of GSK’s Global Pharmaceuticals business
Andrew first joined GlaxoSmithKline in 1999 holding several roles of increasing importance including North Andes Finance Director based in Venezuela, as well as Corporate Development Director and Southern & Eastern European Finance Director. In 2007 he joined Gilead Sciences as International Director of Financial Planning and Analysis before re-joining the GlaxoSmithKline Group in 2010 within the ViiV Healthcare unit as Head of Corporate Development, Europe and International Finance where he served as Director of ViiV Japan. Andrew most recently completed an assignment in GlaxoSmithKline India as Vice President Finance South Asia and Executive Director of the Indian listed entity, GlaxoSmithKline Pharmaceuticals Limited.
Andrew has a BSc (Hons) in Economics and Accountancy from Loughborough University in the United Kingdom. He is also a Fellowship Chartered Accountant of the ICAEW (Institute of Chartered Accountants in England and Wales) having qualified with Price Waterhouse in London in 1994.